http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010515481-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2007-0004
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 2007-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2010515481-A
titleOfInvention Meibomian gland treatment
abstract In one embodiment consistent with the present invention, a method of treating a mammalian meibomian gland (10) comprises heat adjusted to a temperature sufficient to dissolve an obstruction in the meibomian gland in an eyelid containing the meibomian gland (104). To clear the gland by bringing the occlusion into a fluidized or (dissolved) suspension and maintaining heat for a period of time sufficient to dissolve the occlusion. The gland can then be mechanically treated to exude fluid from the gland (108), and the procedure is performed during or after the period while the occlusion is still flowing or suspended. The Pharmacological treatment of the gland by subsequent use of a local (local or systemic) drug (112) can then be used to help maintain proper flow of lipids from the gland. This summary should not be considered limiting and some embodiments may deviate from the features described in this summary.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10772758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019150589-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016531616-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11458038-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973680-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285040-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10925765-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419753-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10052226-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015503417-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419754-B2
priorityDate 2007-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002078727-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1NNP2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56842206
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE1BNK3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PI70
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PKH2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A286ZV08
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423545215
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA6QP91
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6U272
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH0YX95
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6ZYQ1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ66I23
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1R741

Total number of triples: 39.